Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B5CR
|
|||
| Former ID |
DNC012988
|
|||
| Drug Name |
1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine
|
|||
| Synonyms |
CHEMBL381487; 1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H13ClN4
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)N=C(C(=N2)NN)CC3=CC=C(C=C3)Cl
|
|||
| InChI |
1S/C15H13ClN4/c16-11-7-5-10(6-8-11)9-14-15(20-17)19-13-4-2-1-3-12(13)18-14/h1-8H,9,17H2,(H,19,20)
|
|||
| InChIKey |
SMGDWLQUFKXCFA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1753-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.